PAXIL MAKER 'DEPRESSED' OVER NEW YORK LAWSUIT

Paxil maker GlaxoSmithKline fell into what it calls a deep 'depression' following New York's filing of a lawsuit against the British drug conglomerate alleging that the company misled U.S. doctors on the safety and effectiveness of treating children's psychiatric disorders with its drug Paxil. In a statement released Wednesday morning, the office of New York attorney general Eliot Spitzer charged Glaxo with suppressing unfavorable data from its clinical trials that showed Paxil was not only ineffective in treating children, but also that the drug might trigger suicidal tendencies in some kids and adolescents. GlaxoSmithKline declined to comment, but executives at the company were seen lining up at the local pharmacy to fill their Prozac prescriptions.

Related: Spitzer Sues Glaxo Over Pediatric Paxil